Interventional Oncology Devices | Market Insights | Europe (Supplemental) | 2021
Although the European market for interventional oncology devices will be hindered in the immediate term by the impact of the COVID-19 pandemic, the market will be characterized by procedure volume growth, spurred by enhanced reimbursement, product improvements, and the availability of new technologies.
This Medtech 360 Report provides high-level market metrics for devices used in interventional oncology in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.